Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
Tickers BIIB SAGE
Tags Trading Ideas Benzinga Analyst Ratings
From Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
Tickers AXSM BIIB PRAX RLMD
Tags News Briefs SAGE
From Benzinga
Sage Therapeutics’ stock drops 49% after FDA approves zuranolone for postpartum depression but not for major depressive disorder
Tickers BIIB SAGE
Tags SAGE BIIB
From MarketWatch
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
Tickers AAPL BIIB BNTX EADSY
Tags ELAN RTX Markets
From Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
Tickers BIIB SAGE
Tags Health Care BIIB Large Cap
From Benzinga
FDA approves first-ever pill for postpartum depression in new mothers
Tickers BIIB SAGE SPX
Tags SPX SAGE BIIB
From MarketWatch
Biogen Unusual Options Activity For August 02
Tickers BIIB
Tags BZI/UOA Markets Market News
From Benzinga
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
Tickers BIIB CRSP MRNA
Tags NASDAQ:BIIB,NASDAQ:CRSP,NASDAQ:MRNA MRNA CRSP
From InvestorPlace
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
Tickers BIIB GILD REGN RETA
Tags REGN NASDAQ:REGN,NASDAQ:BIIB,NASDAQ:RETA,NASDAQ:GILD RETA
From InvestorPlace
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Tickers BIIB ESALY RETA
Tags RETA BIIB Recent Press Releases
From Motley Fool
Here's How Much You Would Have Made Owning Biogen Stock In The Last 15 Years
Tickers BIIB
Tags Market News Earnings News
From Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Tickers BIIB DGX ESALF LLY
Tags SPX ESALF DGX
From MarketWatch
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
Tickers AAL ADM AMGN AMT
Tags SLB AR FSLR
From Benzinga
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
Tickers BIIB LLY
Tags BIIB Recent Press Releases LLY
From Motley Fool
Could This Stock Be the Next Biotech Buyout?
Tickers BBIO BIIB PFE RETA
Tags BBIO PFE RETA
From Motley Fool
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
Tickers BIIB BMY ESAIY EXAI
Tags EXAI NYSE:GSK,NYSE:PFE,NASDAQ:EXAI,NYSE:BMY,OTCMKTS:ESAIY,NASDAQ:BIIB PFE
From InvestorPlace
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
Tickers BIIB EXEL ILMN
Tags BIIB NASDAQ:BIIB,NASDAQ:ILMN,NASDAQ:EXEL Stocks to Buy
From InvestorPlace
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
Tickers AMGN BIIB DSGN HZNP
Tags Small Cap Biotech Health Care
From Benzinga
Health Care Company Biogen Announces Acquisition of Reata Pharmaceuticals
Tickers BIIB RETA
Tags Benzinga RETA Trading Ideas
From Benzinga
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
Tickers AZN BIIB PFE RETA
Tags BIIB RETA PFE
From MarketWatch
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
Tickers BIIB ENPH PLTR RETA
Tags NASDAQ:RETA,NASDAQ:BIIB,NYSE:XPEV,NYSE:PLTR,NASDAQ:ENPH BIIB Today's Market
From InvestorPlace
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
Tickers BIIB RETA
Tags RETA General M&A
From Benzinga
Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering
Tickers BIIB RETA SPX XBI
Tags SPX BIIB RETA
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Tickers AURA BA BIDU BIIB
Tags STX COTY Analyst Ratings
From Benzinga
I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO
Tickers BIIB
Tags Market News BIIB Recent Press Releases
From Motley Fool
Why Sage Therapeutics Stock Is Tumbling Today
Tickers BIIB SAGE
Tags Market News SAGE BIIB
From Motley Fool
Analyst Ratings for Biogen
Tickers BIIB
Tags Market News Analyst Ratings BIIB
From Benzinga
Why Biogen Stock Got Sick Today
Tickers BIIB
Tags BIIB Recent Press Releases Market News
From Motley Fool
Biogen (BIIB) Q2 2023 Earnings Call Transcript
Tickers BIIB
Tags Market News BIIB Recent Press Releases
From Motley Fool
Biogen to slash 1,000 jobs as it looks to save $700 million
Tickers BIIB ESALF LLY SAGE
Tags SPX ESALF LLY
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.